Development of Medications for the Treatment of Opiate and Cocaine Addictions
eBook - PDF

Development of Medications for the Treatment of Opiate and Cocaine Addictions

Issues for the Government and Private Sector

,
  1. 271 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Development of Medications for the Treatment of Opiate and Cocaine Addictions

Issues for the Government and Private Sector

,

About this book

Pharmacotherapy, as a means of treating drug addiction in combination with other treatment modalities, has received too little attention from the research community, the pharmaceutical industry, public health officials, and the federal government. Medications to combat drug addiction could have an enormous impact on the medical consequences and socioeconomic problems associated with drug abuse, both for drug-dependent individuals and for American society as a whole. This book examines the current environment for and obstacles to the development of anti-addiction medications, specifically those for treating opiate and cocaine addictions, and proposes incentives for the pharmaceutical industry that would help overcome those obstacles and accelerate the development of anti-addiction medications.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Development of Medications for the Treatment of Opiate and Cocaine Addictions by in PDF and/or ePUB format. We have over one million books available in our catalogue for you to explore.

Information

Publisher
National Academies Press
Year
1995
eBook ISBN
9780309587914
Edition
0
Topic
Psychology
Index
Psychology

Table of contents

  1. Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector
  2. Copyright
  3. Acknowledgments
  4. Preface
  5. Note to the Reader
  6. Contents
  7. Executive Summary
  8. 1 Introduction
  9. 2 Overview of the State of Scientific Knowledge Concerning Drug Addiction
  10. 3 Assessment of the Medications Development Division
  11. 4 Treatment Setting and Effectiveness
  12. 5 Treatment Financing and Trends in Health Insurance
  13. 6 Training and Education
  14. 7 Federal Laws and Regulations
  15. 8 State Laws and Regulations
  16. 9 Market Obstacles and Creating Incentives
  17. Appendix A Acknowledgements
  18. Appendix B Organization and Mission Statements of NIDA's Medications Development Division and Its...
  19. Appendix C Diagnostic Criteria for Psychoactive Substance Dependence
  20. Appendix D Survey of Pharmaceutical Companies
  21. Appendix E Model Federal Programs in Pharmaceutical R&D
  22. Appendix F Workshop Agenda and Participants
  23. Appendix G Health Care Reform Legislation
  24. Appendix H Acronyms